When: Pullback to $135-140 zone following Q1 FY27 print that holds as support on retest with declining volume

Then: Re-enter, confirms bottom is in with cleaner risk/reward

When: Trailing four-quarter FCF turns positive

Then: Re-enter on fundamental improvement

When: FY27 capex guide moderates below $50B

Then: Re-enter on capex de-escalation

When: Successful debt issuance at compressed spreads

Then: Re-enter, demonstrates capital market access intact

When: First post-print bounce

Then: Wait for catalyst to clear and structure to confirm before re-engaging

SELL - support 40% trim (vs 30%), tighten third tranche entry conditions to require confirmed close above $155.41 with follow-through OR rejection at 50 SMA; support hard stop at $143.20

• Technical target at 200 SMA $176 is reasonable given 38% drawdown recovery, but bullish target to 'north of 200' based on Forward PE re-rating is speculation requiring flawless multi-variable execution
• CapEx reality: TTM $55.66B (119% ramp), $44B new debt in 9 months, negative FCF -$24.54B TTM, net debt up 20% YoY to $98.25B - Q4 step-down alone doesn't confirm 'digestion not roll-over'
• Technical discipline: wait for confirmed close above $155.41 (50 SMA) with follow-through day before adding; 5 up days post-crash is momentum, not confirmation - could be short covering, dead cat bounce, or rotation money
• Beta 1.72 creates symmetric downside amplification on sector contagion from AI infrastructure names - Burry thesis risk applies to ORCL despite different primary targets
• $1.09T lease commitment overhang is a balance sheet problem that reprices entire AI infrastructure cohort if macro turns or hyperscaler capex disappoints
• Quantinuum partnership: $8M revenue with 279% growth off tiny base doesn't move needle on $67B Oracle TTM revenue; market already priced in marginal value on announcement day
• Forward PE 14x requires 87% EPS expansion ($10.90 vs $5.83 TTM) - any single miss on revenue growth, margin expansion, capex plateau, or CIP conversion triggers multiple compression
• Macro: 36% probability of one Fed hike priced in, zero cuts for 2026 - higher for longer is hostile to long-duration AI cash flows and makes $1.09T lease pipeline financing more expensive
• Preferred trim: ~40% instead of 30%; third tranche entry requires either confirmed close above $155.41 with follow-through OR meaningful bounce rejected at 50 SMA (whichever first)
• Positive factors acknowledged: ROE 53.4%, accelerating revenue, expanding margins, elite profitability - but 'quality at the wrong price' still means wrong price given current setup

→ vs aggressive: 0.6 risk/reward framing is not 'intellectually dishonest' - it's a reasonable technical anchor; the alternative requires multi-variable optimization (capex conversion, margin expansion, $10.90 EPS delivery) with execution risk at every node

→ vs aggressive: CapEx 'digestion' reframing ignores the fundamental picture: $55.66B TTM capex, $44B new debt, -$24.54B FCF - a single quarter dip after 119% ramp could mean demand visibility is weaker, not stronger

→ vs aggressive: 'Confirmation might never come at 155.41' describes the cost of discipline, not a reason to abandon it - waiting avoids being exit liquidity when bounce fails at 200 SMA retest

→ vs aggressive: Burry dismissal ignores Beta 1.72 - ORCL amplifies downside as much as upside; same beta that benefits bullish momentum creates symmetric sector contagion risk

→ vs aggressive: Forward PE 14x is the 'most dangerous claim' - 87% earnings expansion requires flawless execution across five concurrent dependencies; market won't pay 14x for negative FCF company with rising debt

→ vs aggressive: 'Soft CPI and 8% recession probability' macro argument ignores 36% probability of one Fed hike, zero cuts for 2026, and higher-for-longer hostility to AI long-duration cash flows

SELL (partial trim)

• Short-term momentum has turned bullish (MACD crossover, histogram expanding, RSI at 59.66, price above 10 EMA)
• Intermediate and long-term structure remains damaged (50 SMA and 200 SMA overhead with price closed $2.13 below 50 SMA)
• Trim 15-20% total exposure via two tranches instead of three
• First tranche: 1/3 of trim (5-7% of total position) on any rally toward $155.41 key resistance
• Second tranche: 2/3 of trim (10-13% of total position) if stock fails to reclaim $155.41 within 5-7 trading sessions AND RSI rolls over
• Hard stop at $143.20 on closing basis (10 EMA dynamic support, approximately 1.5x ATR from current levels)
• Remove automatic third tranche ahead of Q1 FY27 print - reassess positioning 7-10 days prior
• Q1 FY27 earnings print is approximately 4 weeks away
• Macro environment is supportive for risk assets but not determinative
• Sentiment data is inconclusive (StockTwits unavailable, Reddit empty, institutional flow split)
• A 40% trim is itself a directional bearish bet, not truly conservative

→ vs aggressive: Adding before confirmation at $155.41 is momentum trading dressed as fundamental analysis; price closed $2.13 below the 50 SMA today

→ vs aggressive: The 87% earnings expansion (TTM to Forward EPS) is a 'five-leg parlay' requiring capex to plateau, CIP conversion, margin expansion, and no major restructuring

→ vs aggressive: Using Nebius and CoreWeave as validation for Oracle's $40B CIP conversion is conflating sector validation with company-specific execution

→ vs aggressive: Beta of 1.72 works symmetrically - claiming beta amplification on upside while ignoring downside is not analysis

→ vs conservative: 40% trimming is itself a directional bet that the downside is more likely than upside - that's bearish positioning, not conservative positioning

→ vs conservative: The 200 SMA at $176 is a lagging indicator, not a fundamental price target - the risk/reward framing is not clean

→ vs conservative: Dismissing Quantinuum partnership as immaterial ($8M revenue) ignores the option value of owning quantum distribution to enterprise customers ahead of competitors in an AI infrastructure narrative